Literature summary extracted from
Mittal, N.; Morada, M.; Tripathi, P.; Gowri, V.S.; Mandal, S.; Quirch, A.; Park, M.H.; Yarlett, N.; Madhubala, R.
Cryptosporidium parvum has an active hypusine biosynthesis pathway (2014), Mol. Biochem. Parasitol., 195, 14-22.
Application
EC Number |
Application |
Comment |
Organism |
---|
2.5.1.46 |
drug development |
Cryptosporidium parvum DHS is a traget for drug development, as GC7 effectively inhibits parasite infection and growth in cultured host cells |
Cryptosporidium parvum |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
2.5.1.46 |
gene DHS, DNA and amino acid sequence determination and analysis, sequence comparisons and phylogenetic analysis, recombinant expression of His-tagged enzyme in Escherichia coli strain BL21(DE3) |
Cryptosporidium parvum |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
2.5.1.46 |
1,8-diaminooctane |
weaker inhibition |
Cryptosporidium parvum |
|
2.5.1.46 |
diaminononane |
weaker inhibition |
Cryptosporidium parvum |
|
2.5.1.46 |
N1-guanyl-1,7-diaminoheptane |
GC7, a potent competitive inhibitor of DHS, causes an effective inhibition of infection and growth of Cryptosporidium parvum in human HCT-8 adenocarcinoma cells. Complete inhibition at 0.01 mM |
Cryptosporidium parvum |
|
2.5.1.46 |
paromomycin |
inhibits oocysts formation |
Cryptosporidium parvum |
|
KM Value [mM]
EC Number |
KM Value [mM] |
KM Value Maximum [mM] |
Substrate |
Comment |
Organism |
Structure |
---|
2.5.1.46 |
0.00091 |
- |
[eIF5A-precursor]-lysine |
pH 7.5, 37°C, heterotetrameric DHS |
Cryptosporidium parvum |
|
2.5.1.46 |
0.0123 |
- |
spermidine |
pH 7.5, 37°C, heterotetrameric DHS |
Cryptosporidium parvum |
|
Molecular Weight [Da]
EC Number |
Molecular Weight [Da] |
Molecular Weight Maximum [Da] |
Comment |
Organism |
---|
2.5.1.46 |
40800 |
- |
- |
Cryptosporidium parvum |
2.5.1.46 |
180000 |
- |
native PAGE |
Cryptosporidium parvum |
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
2.5.1.46 |
[eIF5A-precursor]-lysine + spermidine |
Cryptosporidium parvum |
- |
[eIF5A-precursor]-deoxyhypusine + propane-1,3-diamine |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
2.5.1.46 |
Cryptosporidium parvum |
A3FQA5 |
single-copy gene DHS |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
2.5.1.46 |
recombinant His-tagged enzyme from Escherichia coli strain BL21(DE3) to homogeneity by nickel affinity chromatography |
Cryptosporidium parvum |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
2.5.1.46 |
[eIF5A-precursor]-lysine + spermidine |
- |
Cryptosporidium parvum |
[eIF5A-precursor]-deoxyhypusine + propane-1,3-diamine |
- |
? |
|
Subunits
EC Number |
Subunits |
Comment |
Organism |
---|
2.5.1.46 |
tetramer |
4 * 40800, about, sequence calculation |
Cryptosporidium parvum |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
2.5.1.46 |
CpDHS |
- |
Cryptosporidium parvum |
2.5.1.46 |
DHS |
- |
Cryptosporidium parvum |
Temperature Optimum [°C]
EC Number |
Temperature Optimum [°C] |
Temperature Optimum Maximum [°C] |
Comment |
Organism |
---|
2.5.1.46 |
37 |
- |
assay at |
Cryptosporidium parvum |
pH Optimum
EC Number |
pH Optimum Minimum |
pH Optimum Maximum |
Comment |
Organism |
---|
2.5.1.46 |
9.2 |
- |
assay at |
Cryptosporidium parvum |
Cofactor
EC Number |
Cofactor |
Comment |
Organism |
Structure |
---|
2.5.1.46 |
NAD+ |
required |
Cryptosporidium parvum |
|
Ki Value [mM]
EC Number |
Ki Value [mM] |
Ki Value maximum [mM] |
Inhibitor |
Comment |
Organism |
Structure |
---|
2.5.1.46 |
additional information |
- |
additional information |
inhibition profile in a series of kinetic experiments |
Cryptosporidium parvum |
|
General Information
EC Number |
General Information |
Comment |
Organism |
---|
2.5.1.46 |
evolution |
CpDHS is more closely related to apicomplexan and human DHS than to kinetoplast DHS |
Cryptosporidium parvum |
2.5.1.46 |
additional information |
enzyme structure modelling, model evaluation and comparative structural analysis, overview |
Cryptosporidium parvum |
2.5.1.46 |
physiological function |
hypusination of eIF5A is an important post-translational modification essential for cell proliferation. This modification occurs in a two step processcatalyzed by deoxyhypusine synthase followed by deoxyhypusine hydroxylase |
Cryptosporidium parvum |